IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,040,800 | +77.1% | 159,632 | +136.6% | 0.00% | – |
Q1 2024 | $587,768 | -82.7% | 67,482 | -77.3% | 0.00% | -100.0% |
Q4 2023 | $3,396,662 | -31.4% | 296,911 | -42.3% | 0.00% | -50.0% |
Q3 2023 | $4,954,606 | +104.7% | 514,497 | +126.1% | 0.00% | +100.0% |
Q2 2023 | $2,420,749 | -88.1% | 227,514 | -88.2% | 0.00% | -87.5% |
Q1 2023 | $20,260,279 | +1047.2% | 1,925,882 | +1251.1% | 0.01% | +700.0% |
Q4 2022 | $1,766,071 | +224.0% | 142,540 | +170.8% | 0.00% | – |
Q3 2022 | $545,000 | -80.5% | 52,633 | -78.3% | 0.00% | -100.0% |
Q2 2022 | $2,791,000 | +99.5% | 242,028 | +117.7% | 0.00% | – |
Q1 2022 | $1,399,000 | -46.9% | 111,155 | -50.9% | 0.00% | – |
Q4 2021 | $2,637,000 | -49.6% | 226,157 | -43.5% | 0.00% | -100.0% |
Q3 2021 | $5,228,000 | +70.1% | 400,301 | +67.7% | 0.00% | +100.0% |
Q2 2021 | $3,073,000 | +90.9% | 238,701 | +65.8% | 0.00% | – |
Q1 2021 | $1,610,000 | +70.7% | 143,942 | +73.9% | 0.00% | – |
Q4 2020 | $943,000 | -6.1% | 82,789 | -25.8% | 0.00% | – |
Q3 2020 | $1,004,000 | +208.0% | 111,649 | +253.5% | 0.00% | – |
Q2 2020 | $326,000 | +98.8% | 31,584 | +65.1% | 0.00% | – |
Q3 2019 | $164,000 | -78.3% | 19,125 | -73.8% | 0.00% | -100.0% |
Q4 2018 | $757,000 | +320.6% | 73,073 | +526.2% | 0.00% | – |
Q1 2018 | $180,000 | -32.6% | 11,670 | -34.4% | 0.00% | -100.0% |
Q4 2017 | $267,000 | -16.8% | 17,788 | -12.7% | 0.00% | 0.0% |
Q3 2017 | $321,000 | -43.6% | 20,383 | -32.4% | 0.00% | -50.0% |
Q2 2017 | $569,000 | +193.3% | 30,150 | +165.4% | 0.00% | +100.0% |
Q1 2017 | $194,000 | -11.0% | 11,362 | -17.4% | 0.00% | 0.0% |
Q3 2016 | $218,000 | +56.8% | 13,754 | +8.0% | 0.00% | 0.0% |
Q1 2016 | $139,000 | -34.4% | 12,733 | -22.2% | 0.00% | -50.0% |
Q3 2014 | $212,000 | -78.9% | 16,365 | -75.1% | 0.00% | -84.6% |
Q2 2014 | $1,007,000 | – | 65,658 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $183,240,000 | 17.56% |
HealthInvest Partners AB | 1,450,000 | $16,211,000 | 12.91% |
Healthcare Value Capital, LLC | 200,000 | $2,236,000 | 4.98% |
BRIDGER MANAGEMENT, LLC | 2,852,414 | $31,890,000 | 2.98% |
Camber Capital Management LP | 7,500,000 | $83,850,000 | 2.88% |
13D Management LLC | 658,017 | $7,357,000 | 2.72% |
Brown Capital Management | 20,170,126 | $225,502,000 | 1.68% |
Healthcare Value Capital, LLC | 50,000 | $559,000 | 1.24% |
Zebra Capital Management LLC | 59,122 | $661,000 | 0.73% |
PRICE MICHAEL F | 520,000 | $5,814,000 | 0.70% |